Québec, Canada

René Maltais

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Québec, CA (2010 - 2017)
  • Quebec, CA (2014 - 2021)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Inventor René Maltais in Cancer Treatment

Introduction

René Maltais, an inventive mind hailing from Québec, Canada, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of three patents to his name, Maltais is recognized for his groundbreaking work in developing aminosteroid derivatives and 1,2,3,4-tetrahydroisoquinoline derivatives, particularly focusing on cancer treatments.

Latest Patents

Maltais's latest patents encompass essential advancements in medical chemistry. The first patent details "Aminosteroid derivatives and process for producing same," where Estrane-based and Androstane-based aminosteroid derivatives are described. The patent outlines piperazinyl-steroid compounds that exhibit cytotoxicity against various cancer cell lines, highlighting a promising avenue for future pharmaceutical formulations.

His second patent, "Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases," covers compounds that inhibit steroid sulfatase (STS) and act as selective estrogen receptor modulators (SERMs). These compounds demonstrate potential efficacy in treating hormone-related medical conditions, including breast cancer, prostate cancer, and other significant diseases tied to hormone regulation.

Career Highlights

René Maltais has been influential in his career, working with notable institutions such as Université Laval and Endorecherche, Inc. His academic and professional environments have fostered his innovative spirit and have played a critical role in his patent filings and advancements in medical treatments.

Collaborations

Throughout his journey as an inventor, Maltais has collaborated with esteemed colleagues including Donald Poirier and Fernand Labrie. These partnerships have likely enhanced his research outcomes and contributed to the prolific nature of his innovations in the pharmaceutical field.

Conclusion

René Maltais continues to be a formidable presence in medical research, with his patents paving the way for new treatments targeting cancer and other hormone-dependent conditions. His work exemplifies how innovative thinking and collaboration can lead to advancements that have the potential to save lives and change the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…